US Edition
Published • loading... • Updated
A new antibiotic is positive news—but it will take more to stay ahead of superbugs
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A new antibiotic is positive news—but it will take more to stay ahead of superbugs
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved gepotidacin (Blujepa) — the first new class of antibiotic for urinary tract infections (UTIs) in nearly 30 years. This is a major breakthrough for the millions of women suffering from recurrent UTIs, many of which no longer respond to existing antibiotics as over 90% of UTI bacteria are now resistant to at least one common drug. Gepotidacin works through a novel mec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
